Overview

A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin

Status:
Completed
Trial end date:
2017-10-07
Target enrollment:
Participant gender:
Summary
This is a single-center, Phase 1, open label, randomized, two-sequence, two-period, crossover study to evaluate the drug-drug interaction potential between plazomicin and metformin in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Achaogen, Inc.
Treatments:
Metformin